US scientists have discovered a gene that can identify the risk of heart attack among people under the age of 40 who develop the coronary artery disease (CAD). 

Researchers claim that the new gene would prevent thousands of heart attacks as it predicts the increased risk of heart attack in advance.

Researchers from the Duke University Medical School in North Carolina said that they have found a variation in a particular gene which increases the susceptibility to early coronary artery disease. 

To provide the better health treatment in India, an organization, known as ‘AAPI’ (American Association of Physicians of Indian Origin) is planning to open at least one free clinic in each state of India. 

This organization has more than 46,000 physicians of Indian origin who are now living in the US. They will train the rural medical professionals for early diagnosing and treating many fatal diseases. 

Recent research has revealed that some cancer cells are able to "recover" from doses of chemotherapy that could generally destroy other types of cells.

Earlier it was believed that no cells can survive after the therapy triggered a process called apoptosis, or cell suicide. 

An anti-malaria drug is being developed by the DRDO from an herb found in the north-east, which may be used as a better alternative to usual drugs like Chloroquine.

It was confirmed by Dr. W. Selvamurtyhy, Chief controller of the DRDO (Defence Research and Development Organisation) on Sunday, "Six months back, we discovered the anti-malarial qualities in an herb Gommstema found exclusively in the northeast."

Scientists in Australia and China have found a new way to fight dengue. Till now there is no vaccine or cure for dengue fever. Their study revealed that infecting the Aedes aegypti mosquito species that carry the dengue virus mosquitoes with engineered bacteria known as Wolbachia can cut their lives short and reduce the probability of transmitting dengue and other diseases.

Prostate cancer is the most common cancer in American men. It is estimated that 186,000 cases will be detected last year, and the dreaded disease will claim close to twenty eight thousand lives.

The Food and Drug Administration has given green signal to Degarelix, a novel gonadotrophin-releasing hormone blocker that lowers the level of testosterone, in a different way than other medicines do it, as well as levels of prostate-specific antigen (PSA).